Market Currents
Zalicus (ZLCS +11.1%) takes off after announcing the FDA has approved the sale of 32mg tablets...
-
Monday, August 27, 2012, 12:03 PM ETZalicus (ZLCS +11.1%) takes off after announcing the FDA has approved the sale of 32mg tablets for Covidien's (COV +0.6%) Exalgo pain-relief drug. The sale of 8, 12, and 16mg tablets was approved in 2010. Zalicus receives royalties on Exalgo sakes. (PR)
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
This news story has 2 comments: